We also showed that cisplatin induces the expression of HSP27 and FAO markers (i.e., CPT1A, CD36) in cisplatin-resistant ovarian cancer cells through ROS-dependent mechanisms as NAC treatment attenuates cisplatin induction of HSP27 and FAO. Here, CD36 is linked to ovarian cancer.